20/20 BIOLABS, INC. (AIDX) Operating income 2024–2025
20/20 BIOLABS, INC. (AIDX) annual operating income history from SEC filings — each fiscal year as reported.
-$3.3MFY2025 · since FY2024: -$5.7M → -$3.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.3M | +41.3% |
| FY2024 | -$5.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice